MBX Biosciences, Inc. (NASDAQ:MBX)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$104.3M
- Net margin
- —
Little or no net debt.
- Total debt
- $3.3M
- Cash
- $54.1M
- Debt / equity
- 0.01
Comfortably covers what is due within a year.
- Current assets
- $427.9M
- Current liabilities
- $23.7M
- Current ratio
- 18.08
Consumes cash and must keep raising it.
- Operating cash flow
- -$82.7M
- Free cash flow
- -$85.2M
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 47.7M
- Share growth (1y)
- 42.6%
- Cash runway
- 8 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
MBX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 64.00 K | 60.00 K | 100.00 K | 0.00 | 0.00 |
| Gross Profit | 0.00 | -64.00 K | -60.00 K | -100.00 K | 0.00 | 0.00 |
| SG&A Expense | 9.95 M | 8.79 M | 6.04 M | 4.66 M | 4.08 M | 4.12 M |
| R&D Expense | 30.98 M | 18.47 M | 19.76 M | 19.27 M | 17.72 M | 22.41 M |
| Operating Expenses | 40.93 M | 27.27 M | 25.80 M | 23.93 M | 21.80 M | 26.53 M |
| Operating Income | -40.93 M | -27.27 M | -25.80 M | -23.93 M | -21.80 M | -26.53 M |
| Pretax Income | -37.09 M | -23.52 M | -22.06 M | -21.62 M | -19.41 M | -23.88 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -37.09 M | -23.52 M | -22.06 M | -21.62 M | -19.41 M | -23.88 M |
| EPS (Basic) | -0.78 | -0.50 | -0.49 | -0.63 | -0.58 | -0.71 |
| EPS (Diluted) | -0.78 | -0.50 | -0.49 | -0.63 | -0.58 | -0.71 |
| Shares Outstanding | 47.70 M | 46.58 M | 36.51 M | 34.20 M | 33.45 M | 33.41 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.